| Switching from disposable to reusable insulin pens |
Prescribing bulletin |
March 2026 |
| Drugs used in Diabetes |
Prescribing Data Report |
February 2026 |
| Medicines value tracker – Metformin 1g tablets; opportunity savings realised |
Prescribing bulletin |
May 2025 |
| NHS Medicines Optimisation Opportunities Dashboard |
Prescribing Data Report |
May 2025 |
| Formulary assessment – Hydrocortisone sodium phosphate 5mg/5ml, 10mg/5ml oral solutions |
Formulary assessment tools |
July 2024 |
| Budget impact of metformin 1g immediate release tablet prescribing |
Prescribing bulletin |
June 2024 |
| Formulary assessment – Calcifediol soft capsules |
Formulary assessment tools |
May 2024 |
| Formulary assessment – Fezolinetant (Veoza) |
Formulary assessment tools |
May 2024 |
| Fezolinetant for treating vasomotor symptoms associated with the menopause |
New Drug Evaluations |
May 2024 |
| Social Prescribing: Evidence and Outcomes |
Strategic Insights |
April 2024 |
